Home » Stocks » COO

The Cooper Companies, Inc. (COO)

Stock Price: $345.71 USD 7.73 (2.29%)
Updated December 4, 4:02 PM EST - Market closed
After-hours: $344.00 -1.71 (-0.50%) Dec 4, 4:30 PM

COO Stock Price Chart

Key Info

Market Cap 18.44B
Revenue (ttm) 2.44B
Net Income (ttm) 278.20M
Shares Out 49.10M
EPS (ttm) 5.60
PE Ratio 61.76
Forward PE n/a
Dividend $0.06
Dividend Yield 0.02%

Stock Quote

Trading Day December 4
Last Price $345.71
Previous Close $337.98
Change ($) 7.73
Change (%) 2.29%
Day's Open 335.00
Day's Range 327.44 - 346.68
Day's Volume 454,672
52-Week Range 243.42 - 360.63

COO Stock News

Zacks Investment Research - 9 hours ago

Cooper Companies' (COO) fiscal fourth-quarter earnings reflect weak segmental performance. However, it exceeds expectation as it witnesses faster-than-anticipated recovery.

Seeking Alpha - 18 hours ago

The Cooper Companies, Inc. (COO) CEO Al White on Q4 2020 Results - Earnings Call Transcript

Zacks Investment Research - 1 day ago

Cooper Cos. (COO) delivered earnings and revenue surprises of 1.61% and 0.38%, respectively, for the quarter ended October 2020.

Benzinga - 1 day ago

Shares of Cooper Companies (NYSE:COO) were flat in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share fell 4.24% year over year to $3.16, which be...

GlobeNewsWire - 1 day ago

SAN RAMON, Calif., Dec. 03, 2020 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced financial results for its fiscal fourth quarter and full year ended October 31, 2020.

Zacks Investment Research - 1 week ago

Cooper Cos. (COO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.

Zacks Investment Research - 1 week ago

Cooper Companies' (COO) fiscal fourth-quarter performance is likely to reflect better performance by CVI and CSI.

Zacks Investment Research - 1 week ago

Cooper Companies (COO) continues to benefit from solid CVI and CSI product portfolios.

GlobeNewsWire - 3 weeks ago

SAN RAMON, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) announced today that its Board of Directors elected Teresa S. Madden to the Board as an independent director, e...

Zacks Investment Research - 3 weeks ago

PDCO vs. COO: Which Stock Is the Better Value Option?

Other stocks mentioned: PDCO
Insider Monkey - 3 weeks ago

In this article we are going to use hedge fund sentiment as a tool and determine whether The Cooper Companies, Inc. (NYSE:COO) is a good investment right now. We like to analyze hedge fund sen...

GlobeNewsWire - 1 month ago

SAN RAMON, Calif., Nov. 03, 2020 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced it will release fourth quarter and full year 2020 financial results on Thursday, December 3, 20...

Zacks Investment Research - 1 month ago

3 Dental Supplies Stocks Set to Shine on the Industry's Upturn

Other stocks mentioned: ABC, ALGN, BDX, CAH, HSIC, LH, MCK, PDCO, WST, XRAY
Forbes - 1 month ago

After a 43% rise since the March 23 lows of this year, at the current price of around $348 per share we believe Cooper stock (NYSE: COO), best known for its Cooper Vision lenses, has reached i...

GlobeNewsWire - 1 month ago

Data from NYU Langone Fertility Center Study P resented at  American Society of Reproductive Medicine Annual Meeting

Zacks Investment Research - 2 months ago

Cooper Cos. (COO) reported earnings 30 days ago.

Zacks Investment Research - 2 months ago

Let's keep a watch on potentially strong three stocks in the dental space that have shown promise during the pandemic.

Other stocks mentioned: MCK, SDC
Zacks Investment Research - 2 months ago

Cooper Companies (COO) continues to benefit from solid CVI and CSI product portfolios.

The Motley Fool - 2 months ago

Losing sleep over Tesla's dramatic ups and downs? Consider these conservative choices, so you're not left tossing and turning all night.

Other stocks mentioned: AWK, NEE
GlobeNewsWire - 2 months ago

CooperCompanies, CooperVision and CooperSurgical All Recognized by Fortune Magazine CooperCompanies, CooperVision and CooperSurgical All Recognized by Fortune Magazine

Zacks Investment Research - 2 months ago

The Cooper (COO) saw a big move last session, as its shares jumped nearly 5% on the day, amid huge volumes.

Zacks Investment Research - 3 months ago

Cooper Companies' (COO) fiscal third-quarter earnings reflect dismal segmental performance. However, it exceeded expectation as it witnessed faster-than-anticipated recovery.

Seeking Alpha - 3 months ago

The Cooper Companies, Inc. (COO) CEO Al White on Q3 2020 Results - Earnings Call Transcript

Zacks Investment Research - 3 months ago

Cooper Cos. (COO) delivered earnings and revenue surprises of 44.30% and 7.81%, respectively, for the quarter ended July 2020.

Benzinga - 3 months ago

Shares of Cooper Companies (NYSE:COO) increased 3.97% in after-market trading after the company reported Q3 results.

GlobeNewsWire - 3 months ago

SAN RAMON, Calif., Aug. 31, 2020 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will participate in the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit, on September 23, 2020. B...

Zacks Investment Research - 3 months ago

Cooper Companies' (COO) fiscal third-quarter performance is likely to reflect weak performance by CVI and CSI.

Zacks Investment Research - 3 months ago

Cooper Cos. (COO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.

GlobeNewsWire - 3 months ago

SAN RAMON, Calif., Aug. 19, 2020 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will participate in the Morgan Stanley Virtual 18th Annual Global Healthcare Conference, on September 16, 20...

GlobeNewsWire - 3 months ago

SAN RAMON, Calif., Aug. 13, 2020 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will participate in the 2020 Wells Fargo Virtual Healthcare Conference, on September 10, 2020. Al White, Pre...

GlobeNewsWire - 3 months ago

SAN RAMON, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced it will release third quarter 2020 financial results on Thursday, September 3, 2020, at 4:15 ...

Zacks Investment Research - 3 months ago

PDCO vs. COO: Which Stock Is the Better Value Option?

Other stocks mentioned: PDCO
InvestorPlace - 4 months ago

These 5 healthcare stocks look like the sector's best, with downside protection and room for price appreciation even if the market falters.

Other stocks mentioned: BHC, BMY, MDT, NVST
GlobeNewsWire - 4 months ago

SAN RAMON, Calif., July 09, 2020 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), announced today that consistent with the plan approved by its board of directors to pay annual dividends, th...

GlobeNewsWire - 4 months ago

SAN RAMON, Calif., July 06, 2020 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE:COO) today announced that Holly Sheffield has been appointed President of CooperSurgical effective July 13, 2020, r...

Zacks Investment Research - 5 months ago

Near-Term Outlook Bleak for Medical Dental Supplies Industry

Other stocks mentioned: ABC, ALGN, BDX, CAH, HSIC, LH, MCK, PDCO, XRAY
Benzinga - 5 months ago

Conventional wisdom says that insiders and 10% owners really only buy shares of a company for one reason — they believe the stock price will rise and they want to profit from.

Other stocks mentioned: CI, UBER, AAP, AES, AXS, BMY, CNNE, EPD, FATE, FOX, PK, TFC, VFC
Zacks Investment Research - 5 months ago

Cooper Companies' (COO) fiscal second-quarter earnings reflect dismal segmental performance and decline in revenues.

Seeking Alpha - 5 months ago

The Cooper Companies, Inc. (COO) CEO Al White on Q2 2020 Results - Earnings Call Transcript

Zacks Investment Research - 6 months ago

Cooper Cos. (COO) delivered earnings and revenue surprises of -29.11% and -10.02%, respectively, for the quarter ended April 2020.

GlobeNewsWire - 6 months ago

SAN RAMON, Calif., June 04, 2020 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced financial results for the fiscal second quarter ended April 30, 2020.

Zacks Investment Research - 6 months ago

Cooper Companies' (COO) fiscal second-quarter performance is likely to reflect better-than-expected performance at CVI and CSI.

Zacks Investment Research - 6 months ago

Cooper Cos. (COO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.

Zacks Investment Research - 7 months ago

Cooper Companies (COO) continues to gain traction from its robustly performing CVI and CSI businesses.

The Motley Fool - 7 months ago

There are good reasons to believe that Zoetis, The Cooper Companies, and O'Reilly Automotive will fare well in a downturn.

Other stocks mentioned: ORLY, ZTS
Zacks Investment Research - 8 months ago

Cooper Cos. (COO) reported earnings 30 days ago.

Zacks Investment Research - 8 months ago

MCK vs. COO: Which Stock Is the Better Value Option?

Other stocks mentioned: MCK
GlobeNewsWire - 8 months ago

SAN RAMON, Calif., April 01, 2020 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE:COO) today announced the closing of a new five-year $2.14 billion senior unsecured credit facility, comprised of a...

Zacks Investment Research - 8 months ago

MCK vs. COO: Which Stock Is the Better Value Option?

Other stocks mentioned: MCK
Zacks Investment Research - 8 months ago

Cooper Companies (COO) lifts adjusted earnings per share view for fiscal 2020.

About COO

The Cooper Companies operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia. It also provides range of products and services focusing on women, babies, and families, including medical devices, fertility, genomics, and diagnosti... [Read more...]

Industry
Medical Instruments & Supplies
Founded
1980
CEO
Albert White
Employees
12,000
Stock Exchange
NYSE
Ticker Symbol
COO
Full Company Profile

Financial Performance

In 2019, COO's revenue was $2.65 billion, an increase of 4.76% compared to the previous year's $2.53 billion. Earnings were $466.70 million, an increase of 233.60%.

Financial Statements

Analyst Forecasts

The average 12-month stock price forecast for COO is 344.58, which is a decrease of -0.33% from the latest price.

Price Target
$344.58
(-0.33% downside)